Ángeles Martín-Pozo, Jesús Oteo, David Sáez, Juan-Ignacio Alós. Show Affiliations »
Abstract
Entities: Disease Species
Mesh： See more » Aged, 80 and overAmoxicillin-Potassium Clavulanate Combination/pharmacologyAmoxicillin-Potassium Clavulanate Combination/therapeutic useBacterial Proteins/metabolismCoinfection/drug therapyCoinfection/microbiologyDrug Resistance, Multiple, BacterialEscherichia coli/drug effectsEscherichia coli/enzymologyEscherichia coli/isolation & purificationEscherichia coli Infections/drug therapyEscherichia coli Infections/microbiologyEscherichia coli Proteins/metabolismFemaleHumansKlebsiella Infections/drug therapyKlebsiella Infections/microbiologyKlebsiella pneumoniae/drug effectsKlebsiella pneumoniae/enzymologyKlebsiella pneumoniae/isolation & purificationMeropenemR FactorsThienamycins/therapeutic useUrinary Tract Infections/drug therapyUrinary Tract Infections/microbiologybeta-Lactamases/metabolism
Substances： See more » Bacterial ProteinsEscherichia coli ProteinsThienamycinsAmoxicillin-Potassium Clavulanate Combinationbeta-lactamase CMY-2beta-lactamase SHV-12beta-LactamasesMeropenem
Year: 2012 PMID： 23303263
Source DB: PubMed Journal: Rev Esp Quimioter ISSN： 0214-3429 Impact factor: 1.553